If you have ATTR-CM, you may benefit from additional support beyond what your doctors provide. Transthyretin cardiac amyloidosis (ATTR-CM), an incurable condition that involves a buildup of irregular ...

Please join us Saturday, October 19, 2024, at Huntsman Cancer Institute for an Amyloidosis Patient Support Group and Educational Day in conjunction with Amyloidosis Support Groups. Connect with ...

Caring for someone with ATTR amyloidosis can be physically and emotionally demanding. To reduce the chances of burnout, caregivers should also prioritize their own well-being. Factors such as ...

BORDENTOWN, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases, today ...

LOS ANGELES, CA, March 05, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a ...

March is recognized as Amyloidosis Awareness Month, yet for many in the Black community, this disease remains largely unknown—until it is too late. Amyloidosis is a rare but serious condition caused ...

Amyloidosis occurs when a protein called amyloid builds up in organs such as the heart, kidneys, liver, nerves, and digestive system. Deposits may be body-wide or localized and can lead to organ ...

Care of patients with systemic immunoglobulin light chain (AL) amyloidosis has undergone transformative changes, leading to marked, steady progress in outcomes for patients over the past four decades.

BORDENTOWN, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a clinical-stage biotechnology company developing treatments for rare and ...